Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $76.04 in the prior trading day, Transmedics Group Inc (NASDAQ: TMDX) closed at $78.58, up 3.34%. In other words, the price has increased by $3.34 from its previous closing price. On the day, 1.52 million shares were traded. TMDX stock price reached its highest trading level at $78.99 during the session, while it also had its lowest trading level at $76.28.
Ratios:
Our goal is to gain a better understanding of TMDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.33 and its Current Ratio is at 8.20. In the meantime, Its Debt-to-Equity ratio is 2.47 whereas as Long-Term Debt/Eq ratio is at 2.46.
On October 29, 2024, Oppenheimer reiterated its Outperform rating and also upped its target price recommendation from $200 to $125.
Needham reiterated its Buy rating for the stock on October 29, 2024, while the target price for the stock was revised from $208 to $109.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Nov 11 ’24 when Khayal Tamer I sold 1,458 shares for $90.04 per share. The transaction valued at 131,278 led to the insider holds 20,843 shares of the business.
Basile Edward M sold 6,750 shares of TMDX for $563,994 on Nov 05 ’24. The Director now owns 732 shares after completing the transaction at $83.55 per share. On Nov 01 ’24, another insider, Khayal Tamer I, who serves as the Chief Commercial Officer of the company, sold 1,083 shares for $82.64 each. As a result, the insider received 89,499 and left with 20,843 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TMDX now has a Market Capitalization of 2637262848 and an Enterprise Value of 2740069632. As of this moment, Transmedics’s Price-to-Earnings (P/E) ratio for their current fiscal year is 84.19, and their Forward P/E ratio for the next fiscal year is 50.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 6.30 while its Price-to-Book (P/B) ratio in mrq is 12.56. Its current Enterprise Value per Revenue stands at 6.832 whereas that against EBITDA is 53.582.
Stock Price History:
Over the past 52 weeks, TMDX has reached a high of $177.37, while it has fallen to a 52-week low of $67.77. The 50-Day Moving Average of the stock is -33.25%, while the 200-Day Moving Average is calculated to be -35.65%.
Shares Statistics:
The stock has traded on average 1.55M shares per day over the past 3-months and 1863410 shares per day over the last 10 days, according to various share statistics. A total of 32.67M shares are outstanding, with a floating share count of 32.44M. Insiders hold about 3.35% of the company’s shares, while institutions hold 109.95% stake in the company. Shares short for TMDX as of 1730332800 were 8426990 with a Short Ratio of 5.44, compared to 1727654400 on 6016782. Therefore, it implies a Short% of Shares Outstanding of 8426990 and a Short% of Float of 30.54.
